The Third Annual Hematology Think Tank: Now and Tomorrow will take place April 29–May 1, 2027, in Chicago, Illinois. This highly interactive educational forum brings together internationally recognized leaders in malignant hematology to examine the current state of care while exploring the innovations that will define the future of the field. Through expert presentations, multidisciplinary panel discussions, audience engagement, and select debates, faculty will address emerging data, evolving treatment paradigms, translational research, cellular therapies, precision medicine, and the practical challenges of integrating new evidence into clinical practice. Covering a broad spectrum of hematologic malignancies— including leukemias, lymphomas, myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, and CAR T-cell therapy—the program is designed to foster meaningful collaboration and provide actionable insights that attendees can immediately apply to patient care. Learning Objectives:
- Review recent clinical advances in the treatment of cancers, with a focus on the most relevant data from recent studies and clinical trials.
- Evaluate the role of emerging therapies in cancer treatment, including new medications, targeted therapies, and immunotherapies.
- Apply evidence-based strategies to improve patient outcomes in community oncology settings, focusing on the integration of new treatment approaches.
- Assess and manage side effects and toxicities associated with current and emerging therapies in cancer patients.
- Discuss multidisciplinary care approaches that enhance collaboration between oncologists, pharmacists, nurses, and advanced practitioners in treating cancers.